Search clinical trials for: Dasatinib
Total 1435 results
-
St. Jude Children's Research HospitalNational Cancer Institute (NCI); National Institutes of Health (NIH)RecruitingFrailty | Childhood CancerUnited States
-
Scripps HealthBristol-Myers Squibb; Celgene CorporationWithdrawnLeukemia | Chronic Lymphocytic Leukemia
-
Beijing HospitalChinese Society of Clinical OncologyRecruiting
-
Centre Leon BerardBoehringer IngelheimCompletedHead and Neck Squamous Cell CarcinomaFrance
-
Tragara Pharmaceuticals, Inc.Terminated
-
University of Alabama at BirminghamGlaxoSmithKlineTerminatedOvarian CancerUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Massachusetts General Hospital; Washington University School of Medicine; Gla... and other collaboratorsCompletedNeurofibromatosis 2 | Vestibular Schwannoma | Acoustic Neuroma | NF2 | Auditory TumorUnited States
-
GlaxoSmithKlineCompletedNeoplasms, BreastUnited States, Israel
-
Indiana UniversityGlaxoSmithKlineTerminatedDuctal Carcinoma in SituUnited States
-
GlaxoSmithKlineWithdrawnHealthy SubjectsUnited States
-
University Hospital, BordeauxTerminatedBladder Carcinoma | Cystectomy | Infiltrative Bladder CarcinomaFrance
-
Sun Yat-sen UniversityNot yet recruitingNSCLC | Non-small Cell Lung CancerChina
-
Nanfang Hospital of Southern Medical UniversityRecruitingLeukemia | Leukemia, B-cell | Leukemia, Acute | Leukemia, LymphoblasticChina
-
Mayo ClinicEnrolling by invitation
-
AHS Cancer Control AlbertaTom Baker Cancer CentreRecruitingGlioblastoma | Recurrent Glioblastoma | Recurrent DiseaseCanada
-
GlaxoSmithKlineCompletedNeoplasms, BreastUnited States, Korea, Republic of, Spain
-
GlaxoSmithKlineCompletedNeoplasms, BreastUnited Kingdom, United States, Peru, Israel, Poland, Russian Federation, Korea, Republic of, Thailand, Pakistan, Hungary, India, Canada, France, Mexico, Malaysia, Singapore
-
GlaxoSmithKlineCompleted
-
GlaxoSmithKlineCompletedNeoplasms, BreastJapan
-
First Affiliated Hospital Xi'an Jiaotong UniversityRecruitingPrecursor Cell Lymphoblastic Leukemia-Lymphoma | ALL, Adult | Philadelphia-Positive Acute Lymphoblastic LeukemiaChina
-
Sun Yat-sen UniversityJiangsu Hengrui Pharmaceutical Co., Ltd.Not yet recruitingMetastatic Biliary Tract Cancer | Locally Advanced Biliary Tract CancerChina
-
Duke UniversityBristol-Myers SquibbTerminatedPancreatic Adenocarcinoma | Refractory Solid TumorsUnited States
-
AA SecordCompletedOvarian Cancer | Fallopian Tube Cancer | Peritoneal CancerUnited States
-
University of Kansas Medical CenterTerminatedMetastatic Breast CancerUnited States
-
UNC Lineberger Comprehensive Cancer CenterGlaxoSmithKlineCompletedProstate CancerUnited States
-
Arbeitsgemeinschaft medikamentoese TumortherapieGlaxoSmithKlineTerminatedMetastatic Breast CancerAustria
-
City of Hope Medical CenterNational Cancer Institute (NCI)Completed
-
Peking Union Medical College HospitalJiangsu HengRui Medicine Co., Ltd.RecruitingGestational Trophoblastic NeoplasiaChina
-
University of Alabama at BirminghamGlaxoSmithKline; AbbVie; Breast Cancer Research Foundation of AlabamaActive, not recruitingMetastatic Triple Negative Breast CancerUnited States
-
Shanghai Chest HospitalUnknownRecurrence | Metastasis | Esophageal Squamous Cell Carcinoma | ApatinibChina
-
Boehringer IngelheimApproved for marketing
-
Shenzhen Second People's HospitalRecruitingChronic Myeloid Leukemia | Dasatinib | BCR-ABLChina
-
Weill Medical College of Cornell UniversityBristol-Myers SquibbTerminated
-
Bristol-Myers SquibbCompletedChronic Myeloid Leukemia | Philadelphia-Positive Myeloid LeukemiaBelgium, Netherlands, Spain, United States, Italy, Canada, France, Germany, Peru, Singapore, United Kingdom, Australia, Sweden, Finland, Israel, Ireland, Denmark, Korea, Republic of, Norway, Austria, South Africa, Switzerland
-
Jian FangPeking University First Hospital; Peking University Third Hospital; The Second...Unknown
-
Jiangsu HengRui Medicine Co., Ltd.Fudan UniversityCompleted
-
Stanford UniversityKite PharmaRecruitingLymphoblastic LeukemiaUnited States
-
Bristol-Myers SquibbCompletedMultiple Indications CancerFrance, Poland
-
Massachusetts General HospitalBristol-Myers Squibb; Dana-Farber Cancer Institute; Brigham and Women's HospitalCompleted
-
Baylor Breast Care CenterGlaxoSmithKlineCompleted
-
National Cancer Institute (NCI)NCIC Clinical Trials GroupCompletedBrain and Central Nervous System TumorsCanada
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)Active, not recruitingChronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveUnited States
-
GlaxoSmithKlineCompleted
-
GlaxoSmithKlineCompletedNeoplasms, BreastUnited States, Australia, Germany, Hungary, Poland, Peru, France, Israel, Russian Federation, Spain, Canada, Denmark, Hong Kong, Latvia, Korea, Republic of, China, Belgium, Philippines, Italy, United Kingdom, Argentina, India, New Zealand and more
-
Brown UniversityRhode Island Hospital; Memorial Hospital of Rhode IslandTerminatedA Study of Dasatinib With Concurrent Chemoradiation for Stage III Non-Small Cell Lung Cancer (NSCLC)Non-Small Cell Lung CancerUnited States
-
GlaxoSmithKlineTerminatedLung Cancer, Non-Small CellUnited States, Canada
-
GlaxoSmithKlineCompletedNeoplasms, BreastUnited States, Spain, Israel, Canada, Belgium, United Kingdom, France, Tunisia
-
Hung-Hsueh ChouBristol-Myers Squibb; GlaxoSmithKlineUnknown
-
GlaxoSmithKlineCompletedAdenocarcinomaNetherlands, United States, Peru